Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06015594Completed
Open-label trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Università degli Studi di Cagliari. Primary endpoints: Insulin resistance change at 3 years and Androgen levels change at 3 years. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06015594.